Hydralazine Hydrochloride Tablet
Product Images NDC 50111-397

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 50111-397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 1

Hydralazine Hydrochloride Tablet 089097 088467 088 1
Chemical structure of Hydralazine Hydrochloride, showing a bicyclic ring system with attached hydrazine and hydrochloride groups.*
FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 2

Hydralazine Hydrochloride Tablet 089097 088467 088 2
Label for Hydralazine Hydrochloride Tablets USP 10 mg by Teva Pharmaceuticals USA, Inc. The oral tablet comes in a package of 100 tablets. The label includes dosage strength, NDC 50111-398-01, manufacturer information, and storage instructions, along with a barcode and regulatory information.*
FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 3

Hydralazine Hydrochloride Tablet 089097 088467 088 3
Label for Hydralazine Hydrochloride Tablets USP 25 mg, oral tablet form by Teva Pharmaceuticals USA, Inc. The label indicates a package size of 100 tablets with prescription use only. It includes dosage strength, NDC number 50111-327-01, storage instructions, and manufacturer information.*
FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 4

Hydralazine Hydrochloride Tablet 089097 088467 088 4
Label for Hydralazine Hydrochloride Tablets USP 50 mg from Teva Pharmaceuticals USA, Inc. The label indicates a package containing 100 tablets with the NDC 50111-328-01. It includes storage instructions, prescription status, and manufacturer details.*
FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 5

Hydralazine Hydrochloride Tablet 089097 088467 088 5
Label for Hydralazine Hydrochloride Tablets USP 100 mg oral tablets by Teva Pharmaceuticals USA, Inc., packaged as 100 tablets. The label includes product name, strength, NDC 50111-397-01, and storage instructions to keep at 20 to 25°C. It notes the tablets contain hydralazine hydrochloride USP and are prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.